Amide compounds and medicinal use thereof

Details Amide compounds and medicinal use thereof Amide compounds and medicinal use thereof

2006-03-21

2006-03-21

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S235800, C514S253090, C514S316000, C514S326000, C544S060000, C544S130000, C544S364000, C546S187000, C546S230000

Reexamination Certificate

active

07015218

ABSTRACT:
The present invention relates to a compound of the formulawherein R1is substituted aryl, heteroaryl and the like, R2and R3are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.

REFERENCES:
patent: 4046775 (1977-09-01), Bailey
patent: 4134987 (1979-01-01), Huppatz
patent: 5368854 (1994-11-01), Rennick
patent: 0 459 887 (1991-12-01), None
patent: 226679 (1991-10-01), None
patent: 255757 (1997-11-01), None
patent: 94/04180 (1994-03-01), None
patent: 95/24918 (1995-09-01), None
patent: 97/11690 (1997-04-01), None
Khoury et al., Cellular Immunology, 131, 302-310 (1990).
Mannie et al., Cellular Immunology, 153, 312-328 (1994).
Di marco et al., Clin. Exp. Immunol., 1996, 105: 338-343.
O'Driscoll et al., J. CLin. Invest., vol. 100, No. 3, Aug. 1997, 678-684.
Liu et al., The Journal of Immunology, 2000, 164: 3608-3615.
Annovazzi et al., Diabetes Metab REs REv. Nov.-Dec. 2003; 19(6):464-8.
Villadsen et al., The Journal fo Clinical Investigation, Nov. 2003, vol. 112, No. 10.
Sakai et al., Gastroenterology 1998, 114, pp. 1237-1243.
Kirman et al., The American Journal of Gastroenterology, vol. 91., No. 9, 1996, pp. 1789-1794.
Lampert, Clin Exp Immunol. 1984, 57(1), pp. 93-100, abstract only.
Onuma S., J Dermatol. 1994, 21(4):223-32.
Reidalova, L.I., et al. “Growth-regulating properties of substituted pyrazole-4-(thio)carboxylic acids and their analogs”, Fiziol. Akt. Veshchestva, vol. 23 (1991), pp. 82-87.
Luo. H., et al. “Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin”, Clin. Exp. Immunol., vol. 94 (1993), pp. 371-376.
Wang, A.X., et al. “Synthesis and immunosuppressant activity of pyrazole carboxamides”, Bioorg. Med. Chem. Lett., vol. 8, No. 19, P. 2787-2792 (1998).
Brian S. Andrews et al., “Spontaneous Murine Lupus-Like Syndromes”, J. Exp. Med., vol. 148, pp. 1198-1215, 1978.
Philip L. Cohen, “Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative Disease”, Annual Review of Immunology, vol. 9, pp. 243-269, 1991.

Affiliated with

Also associated with

Rating

Amide compounds and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amide compounds and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide compounds and medicinal use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569079